Tower Research Capital LLC (Trc) Armata Pharmaceuticals, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Armata Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 355 shares of ARMP stock, worth $2,499. This represents 0.0% of its overall portfolio holdings.
Number of Shares
355
Previous 1,705
79.18%
Holding current value
$2,499
Previous $3,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding ARMP
# of Institutions
28Shares Held
755KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA297KShares$2.09 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA105KShares$736,0030.0% of portfolio
-
Edgewood Management LLC Greenwich, CT100KShares$704,0000.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX44.7KShares$314,5610.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny41.3KShares$290,7230.0% of portfolio
About Armata Pharmaceuticals, Inc.
- Ticker ARMP
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,144,700
- Market Cap $254M
- Description
- Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...